Drug Database
Back to search

United States· US:61269-881_f2757843-0b78-46be-a22c-bcdf3a433464

DOCOSANOL

A docosanol product containing docosanol, registered in United States by H2-Pharma, LLC. The same ATC class is registered in 5 of our 19 countries.

ATC D06BB11US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDOCOSANOLATCD06BB11REGISTER NO.US:61269-881_f2757843…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about docosanolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Docosanol is registered in 5 of 19 countries.

Countries holding a registration under ATC D06BB11 (docosanol), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 5 of them publish a price we can compare per daily dose
Search docosanol products by name

Docosanol · ATC D06BB11

5 / 19 countries

  • Belgiumprice
  • Franceprice
  • Polandprice
  • Spainprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DOCOSANOL
Manufacturer
H2-Pharma, LLC
Country
United States (US)
ATC code
D06BB11
ATC class
Docosanol
Defined daily dose
50 mg, T
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    6126988135
    2 g in 1 TUBE (61269-881-35)
  • ndc11
    61269-881-35

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Docosanol in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All docosanol products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Austria · Erazaban
  • Belgium · Erazaban
  • France · Erazaban
  • United Kingdom (Northern Ireland) · Cold Sore, Docosanol Dendron Brands
  • Poland · Erazaban

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bc1ef106-c54d-4413-ab27-4a1d1aebcc55
GET /v1/drugs/bc1ef106-c54d-4413-ab27-4a1d1aebcc55?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": "100",
  "substance": "DOCOSANOL",
  "productndc": "61269-881",
  "dosage_form": "CREAM",
  "dea_schedule": null,
  "strength_unit": "mg/g",
  "application_number": "ANDA212385",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about docosanol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console